Scholar Rock Holding (SRRK) Share-based Compensation (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Share-based Compensation of $18.2 million in Q1 2026, down 6.06% quarter-over-quarter from $19.4 million in Q4 2025, and up 36.02% on a YoY basis from $13.4 million in Q1 2025.

Scholar Rock Holding (SRRK) Share-based Compensation (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Share-based Compensation history runs 10 years deep, the most recent figure standing at $18.2 million for Q1 2026.

  • In Q1 2026, Share-based Compensation rose 36.02% year-over-year to $18.2 million; the TTM figure through Mar 2026 stood at $80.4 million (up 92.07% YoY), while the FY2025 annual figure was $75.6 million, up 106.4% from the prior year.
  • Share-based Compensation was $18.2 million for Q1 2026 at Scholar Rock Holding, down from $19.4 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $24.4 million in Q2 2025 to a low of $6.2 million in Q4 2022.
  • Historically, Share-based Compensation has averaged $10.9 million across 5 years, with a median of $8.2 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Share-based Compensation declined 9.64% in 2023, then jumped 162.41% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $6.2 million in 2022, then gained by 12.75% to $7.0 million in 2023, then surged by 36.7% to $9.5 million in 2024, then jumped by 104.41% to $19.4 million in 2025, then retreated by 6.06% to $18.2 million in 2026.
  • The last three Share-based Compensation figures came in at $18.2 million (Q1 2026), $19.4 million (Q4 2025), and $18.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 18.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.25 Mn
Mar 31, 2026 18.25 Mn
Dec 31, 2025 19.42 Mn
Dec 31, 2025 19.42 Mn
Sep 30, 2025 18.33 Mn
Sep 30, 2025 18.33 Mn
Jun 30, 2025 24.43 Mn
Jun 30, 2025 24.43 Mn
Mar 31, 2025 13.41 Mn
Mar 31, 2025 13.41 Mn
Dec 31, 2024 9.50 Mn
Dec 31, 2024 9.50 Mn
Sep 30, 2024 9.65 Mn
Sep 30, 2024 9.65 Mn
Jun 30, 2024 9.31 Mn
Jun 30, 2024 9.31 Mn
Mar 31, 2024 8.16 Mn
Mar 31, 2024 8.16 Mn
Dec 31, 2023 6.95 Mn
Dec 31, 2023 6.95 Mn